Genentech, Inc. (NYSE:DNA.DL)

CAPS Rating: No stars

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

Recs

0
Player Avatar quinpeung (36.27) Submitted: 2/28/2009 1:18:34 PM : Outperform Start Price: $82.39 DNA.DL Score: +25.53

Roche wants the shares of Genetech that they don't already own, but the board of DNA does not like the offer. Stock will hold steady or even rise slightly until this issue is resolved.

Featured Broker Partners


Advertisement